ALKBH5 and hepatocellular carcinoma: (67) found that ALKBH5 overexpression demethylates the m6A modification in the 3’ UTR of the oncogenic gene SNAI2 to prevent recognition mediated by YTHDF2, thus stabilizing SNAI2 transcripts to maintain cancer stem cell traits in HBV-positive HCC.